Duchenne Muscular Dystrophy: Exon Skipping and PMO technology

Wednesday, December 6, 2017
12:00 PM ET/9:00 AM PT

Click here to register for this live educational webinar where Ms. O’Rourke will review molecular basis of Duchenne Muscular Dystrophy (DMD), describe exon skipping and Phosphorodiamidate Morpholino Oligomer (PMO) technology, and discuss DMD diagnostic testing: challenges and resources. 

 

Erin O’Rourke MS, CGC

Senior Director Global Diagnostics

Medical Affairs

Sarepta Therapeutics

 

ONE contact hour toward ASCLS P.A.C.E. ® credit will be available to participating laboratory professionals who attend the webinar and complete the post evaluation.

Audience:

Genetic Counselors

Geneticists

Neurologists

Internal Medicine

Nurse Practitioners

Physician Assistants

Adult Medicine

Lab Professionals